Top Atlanta, GA Biotech Companies (47)
Don't see your company?
Create a company profile
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
CorDx a multi-national biotech organization focused on pushing the limits of innovation and supply in global health. With over 2,100 employees across the world, serving millions of users in over 100 countries, CorDx delivers rapid testing and point-of-care medical device solutions used in the detection of infectious disease such as COVID-19, pregnancy, drugs of abuse, biomarkers, and more. CorDx is at the cutting edge of technology, artificial intelligence, and data science with the goal of delivering diagnostic solutions to some of the most critical questions in healthcare. #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
StimLabs was founded in 2015 with a desire to advance the state of regenerative medicine. In pursuit of this goal, StimLabs has gathered exceptional scientific and clinical minds to develop and commercialize new bioactive technologies. Within a year of its inception, StimLabs conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
CIS Biotech is a research and development company bringing disease-associated biomarkers and in vitro diagnostic tools to the marketplace.
Clearwave is the healthcare industry’s most comprehensive patient engagement platform. Listed as one of Technology Association of Georgia's Top 40 Innovative Companies and a finalist for the 2020 TripleTree iAwards, Clearwave's technology has empowered specialty practices and health systems to improve profitability, productivity and patient access since 2004. Healthcare organizations choose Clearwave for its ability to simplify patient scheduling, expedite patient intake, automate insurance eligibility verification and create true financial transparency for both patient and practice. Clearwave helps practices accelerate cash flow and improve digital patient access. For more information, visit www.clearwaveinc.com. We aim to make the lives of specialty medical practices and health systems simpler, allowing them to focus on what truly matters – patient care.
AlphaCord is a stem cell banking company.
Chemily, LLC specializes in cost-effective synthesis of glycan libraries, carbohydrate-based biochemicals, reagents and pharmaceuticals.
At Rare Disease Research, we aim to optimize the process of conducting clinical trials in rare disease conditions. To improve access to investigational therapies, increase opportunities for trial participation, patient recruitment and retention, we have an experienced team with a multidisciplinary approach to orchestrate clinical research trials in rare disease conditions. We closely collaborate with sponsors, CRO, and patient advocacy groups to improve awareness and recruitment for cutting edge clinical trials. Because rare diseases are not often considered a public health matter, we tirelessly advocate for newborn screenings. We want to improve health outcome for infants with rare genetics conditions who otherwise would have to endure diagnosis odyssey and delayed treatment. Our newborn screening project for Spinal Muscular Atrophy will begin in 2018.
Vivex Biomedical is a biomedical company developing implant technology and stem cell therapies.
Omega Bio-tek provides nucleic acid purification solutions, offering products for clinical and basic research, biotech and agricultural applications.
MiMedx is a biopharmaceutical company.
Antios Therapeutics is a clinical-stage biopharmaceutical company.
GEMÜ is a leading manufacturer of valves, measurement and control systems. Over the course of more than 50 years, this globally focused, independent family-owned enterprise has established itself in important industrial sectors thanks to its innovative products and customized solutions for process media control. GEMÜ is the world market leader for sterile valve applications in the pharmaceutical and biotechnology industries. Today, the GEMÜ Group employs about 100 people in the United States, 1000 employees in Germany and more than 1700 worldwide. Manufacturing is carried out at six manufacturing sites in Germany, Switzerland, China, Brazil, France and the USA.
Caprico Biotechnologies, Inc. is a startup located in Norcross, Georgia focusing in antibody production for flow cytometry and immunohistochemistry.
AventaCell BioMedical Corp. develops novel human-derived products for use in cell culture and tissue regeneration.
Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.
Work Your Passion. Live Your Purpose.
